Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Dapoxetine in Rapid Ejaculation
NCT01230762Phase 3Completed
- Sponsor
- ALZA Corporation
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of dapoxetine in premature ejaculation (PE), sponsored by ALZA Corporation. Status: completed.
02
Drugs
dapoxetine
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT01230762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01230762.